Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in… US FDA label
Use: VIGAMOX ® is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* Micrococcus luteus* Staphylococcus aureus Staphylococcus… US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per ml ophthalmic solution: 5 mg/1 mg
- Per ml sterile ophthalmic solution: 5 mg/1 mg
Registered products in the Philippines
17 products registered with the Food and Drug Administration (FDA) Philippines list Dexamethasone + Moxifloxacin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products17
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AfreemodexaMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v / 0.1% w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Bliss Pharma Distribution And Consultancy Corp.Importer: Afree Pharmaceuticals Distribution Corp. | DRP-13712-01 | Mar 30, 2028 | |
AguamoxMoxifloxacin (as hydrochloride) + Dexamethasone Phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v / 0.1% w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Agua Visions TradingImporter: Afree Pharmaceutical Distribution Corp. | DRP-13712-02 | Mar 30, 2028 | |
BelvadoxMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v / 0.1% w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Belvadar Pharmaceuticals Inc.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13712-03 | Mar 30, 2028 | |
IKSHADEXMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v / 0.1% w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Bliss Pharma Distribution and Consultancy Corp.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13712-06 | Mar 30, 2028 | |
Lumemox-DMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v/0.1% w/v) Sterile Ophthalmic Solution (Eye Drops)LDPE Plastic Droptainer with Spike Cap x 5 mL (Box of 1's) | Rx | Axa Parenterals LimitedIndia | Brady Pharma Inc. | DRP-11511 | Mar 30, 2027 | |
Milflox DmMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5%/0.1% w/v) Sterile Ophthalmic Solution5 mL (net content) white opaque LDPE dropper bottle with white opaque LDPE plug and white opaque HDPE pilfer-proof cap (Box of 1's) | Rx | Sun Pharmaceutical Industries Ltd.India | Sun Pharma Philippines, Inc.Trader: Sun Pharmaceutical Industries Limited | DR-XY48243 | Dec 10, 2026 | |
Milflox DmMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5%/0.1% w/v) Sterile Ophthalmic Solution5 mL (net content) white opaque LDPE dropper bottle with white opaque LDPE plug and white opaque HDPE pilfer-proof cap (Box of 1's) | Rx | Sun Pharmaceutical Medicare LimitedIndia | Sun Pharma Philippines, Inc. | DRP-10875 | Dec 10, 2026 | |
ModexCareMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v / 0.1% w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Sensorycare Pharma Co.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13712-07 | Mar 30, 2028 | |
ModiximMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v / 0.1% w/v) Ophthalmic Solution5 mL Opaque Plastic Bottle with Nozzle and Cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Bliss Pharma Distribution and Consultancy Corp.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13712-11 | Mar 30, 2028 | |
MOXFOZ DMMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v / 0.1% w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Ophtha Pharma Traders Inc.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13712-10 | Mar 30, 2028 | |
Moxfoz DMMoxifloxacin (as Hydrochloride) + Dexamethasone Phosphate (as Sodium) | 5 mg/1 mg per mL (0.5% w/v/ 0.1% w/v) Sterile Ophthalmic Solution10 mL opaque LDPE bottle, white opaque LDPE nozzle and white opaque HDPE cap (Box of 1's) | Rx | Indiana OphthalmicsIndia | Ophtha Pharma Traders Inc.Importer: Medinova Pharmaceutical Inc. | DRP-13586-01 | Mar 14, 2028 | |
MoxidexMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg / 1 mg per mL (0.5 % w/v / 0.1 % w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Marzeal Marketing OPCImporter: Afree Pharmaceutical Distribution Corp. | DRP-13712-04 | Mar 30, 2028 | |
MoxiflamMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v / 0.1% w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Envision Inc.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13712-05 | Mar 30, 2028 | |
OphthamoxMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5% w/v / 0.1% w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Victorious King Pharmaceutical and Medical Supplies Inc.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13712-09 | Mar 30, 2028 | |
Opthomox DXMoxifloxacin (as Hydrochloride) + Dexamethasone Phosphate (as Sodium) | 5 mg/1 mg per mL (0.5% w/v/ 0.1% w/v) Sterile Ophthalmic Solution10 mL opaque LDPE bottle, white opaque LDPE nozzle and white opaque HDPE cap (Box of 1's) | Rx | Indiana OphthalmicsIndia | Medinova Pharmaceutical Inc. | DRP-13586 | Mar 14, 2028 | |
QuinodexMoxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium) | 5 mg/1 mg per mL (0.5%w/v/0.1% w/v) Ophthalmic Solution5 mL opaque plastic bottle with nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | JNJ Pharma EnterprisesImporter: Afree Pharmaceutical Distribution Corp. | DRP-13712-08 | Mar 30, 2028 | |
VigadexaMoxifloxacin (as hydrochloride) + Dexamethasone Phosphate (as sodium) | 5 mg/1 mg per mL Sterile Ophthalmic SolutionLDPE Bottle (droptainer) x 5 mL (Box of 1's); LDPE Bottle (droptainer) x 2.5 mL (as physician's sample) (Box of 1's) | Rx | Neolab Solucoes Farmacêuticas Estéreis Do Brasil LtdaBrazil | Importer: Novartis Healthcare Philippines, Inc. | DR-XY36426 | Nov 29, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .